SEC Filing Details

Document Details

Form
3
Filing Date
Sep 5, 2019
Document Date
Sep 3, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
Amado Rafael